4//SEC Filing
Kessler Paul D. 4
Accession 0001491877-12-000022
CIK 0000072444other
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 4:21 PM ET
Size
5.0 KB
Accession
0001491877-12-000022
Insider Transaction Report
Form 4
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Transactions
- Sale
Common Stock
2012-04-05$1.90/sh−5,167$9,817→ 105,128 total
Footnotes (1)
- [F1]This disposition was effected pursuant to a 10b-5 trading plan and was made to fund the Reporting Person's tax obligation arising from the vesting of restricted stock.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001428524
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 4:21 PM ET
- Size
- 5.0 KB